tinosorb s
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
1
Earliest trial started Sep 1, 2012 (NCT01695356)
Timeline
Indications
Approved for
Mechanism of action
- Unspecified targetUltraviolet filter
ultraviolet filter
Chemistry & pharmacology
Loading structure…
SMILES
CCCCC(CC)COc1ccc(-c2nc(-c3ccc(OC)cc3)nc(-c3ccc(OCC(CC)CCCC)cc3O)n2)c(O)c1- Mol. weight
- 627.83 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2104956 ↗
Also known as
- bemotrizinol
- bemotrizinol
- bemotrizinol
- bemotrizinol
- bemotrizinol
- bemotrizinol
- bis-ethylhexyloxyphenol methoxyphenyl triazine
- bis-ethylhexyloxyphenol methoxyphenyl triazine
- bis-ethylhexyloxyphenol methoxyphenyl triazine
- tinosorb s
- tinosorb s
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05277376 | Phase 3 | Mar 15, 2022 | DSM, Spaulding Clinical Research Inc. |
| NCT04355286 | Phase 1 | Jun 30, 2020 | DSM, Spaulding Clinical Research Inc. |
| NCT01695356 | Phase 4 | Sep 1, 2012 | Universidad Autonoma de San Luis Potosi |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| DSM | For profit | 2 | 2 | 2 | 2020 |
| Spaulding Clinical Research Inc. | For profit | 2 | 0 | 2 | 2020 |
| Universidad Autonoma de San Luis Potosi | Academic/Hospital | 1 | 1 | 1 | 2012 |
3 organizations
Page 1 / 1